The present invention is directed to 5-membered heteroaryl compounds containing a hydroxamate moiety of Formula I, pharmaceutically acceptable salts or solvates thereof, and their use as sensitizers for chemotherapy of malignant tumors.
本发明涉及含有Formula I的羟
肟基团的5-成员杂芳化合物,其药用可接受盐或溶剂,以及它们作为恶性肿瘤化疗的增敏剂的用途。